121 related articles for article (PubMed ID: 3038401)
1. Antihypertensive action of angiotensin-I converting enzyme inhibitors in the kidney.
Matsukawa S; Suzuki H; Itaya Y; Kumagai H; Saruta T
Clin Exp Hypertens A; 1987; 9(2-3):391-4. PubMed ID: 3038401
[TBL] [Abstract][Full Text] [Related]
2. The renal antihypertensive effect of angiotensin I converting enzyme inhibitors.
Matsukawa S; Suzuki H; Itaya Y; Kumagai H; Saruta T
J Hypertens; 1987 Dec; 5(6):705-10. PubMed ID: 2448369
[TBL] [Abstract][Full Text] [Related]
3. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Zimmerman BG; Goering JL; Raich PC
Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
[TBL] [Abstract][Full Text] [Related]
4. Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Tomlinson KC; Gardiner SM; Bennett T
J Cardiovasc Pharmacol; 1990 Apr; 15(4):562-8. PubMed ID: 1691384
[TBL] [Abstract][Full Text] [Related]
5. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
[TBL] [Abstract][Full Text] [Related]
6. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
Oda M; Ino Y; Suzuki K; Sato T; Iwamoto S; Iwaki M
Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
[TBL] [Abstract][Full Text] [Related]
7. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
Chiba S; Quilley CP; McGiff JC
Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
[TBL] [Abstract][Full Text] [Related]
8. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.
Antonaccio MJ; Kerwin L
Hypertension; 1981; 3(3 Pt 2):I54-62. PubMed ID: 6167515
[TBL] [Abstract][Full Text] [Related]
9. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog.
Zimmerman BG; Raich PC; Vavrek RJ; Stewart JM
Circ Res; 1990 Jan; 66(1):234-40. PubMed ID: 2153061
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
12. Different responses of renal blood flow and sympathetic nerve activity to captopril and nicardipine in conscious renal hypertensive rabbits.
Kumagai H; Suzuki H; Ichikawa M; Nishizawa M; Ryuzaki M; Kumagai K; Saruta T
J Cardiovasc Pharmacol; 1995 Jan; 25(1):57-64. PubMed ID: 7723354
[TBL] [Abstract][Full Text] [Related]
13. The effect of renin-angiotensin system blockade on visceral blood flow during and after thoracic aortic cross-clamping.
Joob AW; Harman PK; Kaiser DL; Kron IL
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):411-8. PubMed ID: 3005777
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
Kubo SH; Cody RJ
Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
[TBL] [Abstract][Full Text] [Related]
15. Specificity of renal vasodilation with captopril: saralasin prevents the response in the DOCA-treated, salt-loaded rabbit.
Hollenberg NK; Passan DR
Life Sci; 1982 Jul; 31(4):329-34. PubMed ID: 6755124
[TBL] [Abstract][Full Text] [Related]
16. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
Textor SC; Brunner HR; Gavras H
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
[TBL] [Abstract][Full Text] [Related]
19. Comparison of systemic and intrarenal converting enzyme inhibition by MK-422 on renal hemodynamics in conscious dogs.
Zimmerman BG; Finis CJ
J Cardiovasc Pharmacol; 1985; 7(4):715-22. PubMed ID: 2410713
[TBL] [Abstract][Full Text] [Related]
20. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
